BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 38531807)

  • 1. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
    Xu D; Wang Z; Li F
    Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification.
    Zhang Z; Guo J; Gong C; Wu S; Sun Y
    Cancer Biomark; 2024 Feb; ():. PubMed ID: 38427468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Arumugam P; George R; Jayaseelan VP
    Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA.
    Cheng X; Li M; Rao X; Zhang W; Li X; Wang L; Huang G
    Onco Targets Ther; 2019; 12():3421-3428. PubMed ID: 31118692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
    Xu T; Zhang W; Chai L; Liu C; Zhang S; Xu T
    Oral Dis; 2023 Mar; 29(2):639-648. PubMed ID: 34479400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
    Chen X; Fan R
    J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential.
    Sun X; Fu S; Yuan X; Pu X; Wang R; Wang X; Lu H
    Cancer Gene Ther; 2023 Sep; 30(9):1209-1214. PubMed ID: 37221404
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.